181 related articles for article (PubMed ID: 15970540)
1. Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms.
Ichikawa M; Chen L
Front Biosci; 2005 Sep; 10():2856-60. PubMed ID: 15970540
[TBL] [Abstract][Full Text] [Related]
2. Fine tuning the immune response through B7-H3 and B7-H4.
Yi KH; Chen L
Immunol Rev; 2009 May; 229(1):145-51. PubMed ID: 19426220
[TBL] [Abstract][Full Text] [Related]
3. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
[TBL] [Abstract][Full Text] [Related]
4. T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.
Lu B; Chen L; Liu L; Zhu Y; Wu C; Jiang J; Zhang X
Immunol Res; 2011 Aug; 50(2-3):269-75. PubMed ID: 21717068
[TBL] [Abstract][Full Text] [Related]
5. Potential targeting of B7-H4 for the treatment of cancer.
Podojil JR; Miller SD
Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
[TBL] [Abstract][Full Text] [Related]
6. Immunology of B7-H1 and its roles in human diseases.
Tamura H; Ogata K; Dong H; Chen L
Int J Hematol; 2003 Nov; 78(4):321-8. PubMed ID: 14686489
[TBL] [Abstract][Full Text] [Related]
7. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
8. B7-H1 pathway and its role in the evasion of tumor immunity.
Dong H; Chen L
J Mol Med (Berl); 2003 May; 81(5):281-7. PubMed ID: 12721664
[TBL] [Abstract][Full Text] [Related]
9. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.
Kryczek I; Zou L; Rodriguez P; Zhu G; Wei S; Mottram P; Brumlik M; Cheng P; Curiel T; Myers L; Lackner A; Alvarez X; Ochoa A; Chen L; Zou W
J Exp Med; 2006 Apr; 203(4):871-81. PubMed ID: 16606666
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
11. Could B7-H4 serve as a target to activate anti-cancer immunity?
Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
[TBL] [Abstract][Full Text] [Related]
12. B7-H4, a promising target for immunotherapy.
Wang JY; Wang WP
Cell Immunol; 2020 Jan; 347():104008. PubMed ID: 31733822
[TBL] [Abstract][Full Text] [Related]
13. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
14. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
Immunity; 2003 Jun; 18(6):849-61. PubMed ID: 12818165
[TBL] [Abstract][Full Text] [Related]
15. New checkpoints in cancer immunotherapy.
Ni L; Dong C
Immunol Rev; 2017 Mar; 276(1):52-65. PubMed ID: 28258699
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent.
Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
Scand J Immunol; 1999 Sep; 50(3):242-9. PubMed ID: 10447932
[TBL] [Abstract][Full Text] [Related]
17. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.
Wang YH; Cao YW; Yang XC; Niu HT; Sun LJ; Wang XS; Liu J
Asian Pac J Cancer Prev; 2014; 15(3):1321-6. PubMed ID: 24606459
[TBL] [Abstract][Full Text] [Related]
18. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
[TBL] [Abstract][Full Text] [Related]
19. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity.
Zhu G; Augustine MM; Azuma T; Luo L; Yao S; Anand S; Rietz AC; Huang J; Xu H; Flies AS; Flies SJ; Tamada K; Colonna M; van Deursen JM; Chen L
Blood; 2009 Feb; 113(8):1759-67. PubMed ID: 19109567
[TBL] [Abstract][Full Text] [Related]
20. Immunopathogenesis of ovarian cancer.
Torres MP; Ponnusamy MP; Lakshmanan I; Batra SK
Minerva Med; 2009 Oct; 100(5):385-400. PubMed ID: 19910891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
